Clinical trial
Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
NCT00234689 · Sheba Medical Center, Other · Completed
Key facts
| NCT number | NCT00234689 |
|---|---|
| Title | Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obsessive Compulsive Disorder |
| Intervention type | Drug |
| Interventions | Naltrexone |
| Start date | Jan 1, 2002 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Oct 7, 2005 |
| Last update posted | Jan 30, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: